IS7100A - Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera - Google Patents

Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera

Info

Publication number
IS7100A
IS7100A IS7100A IS7100A IS7100A IS 7100 A IS7100 A IS 7100A IS 7100 A IS7100 A IS 7100A IS 7100 A IS7100 A IS 7100A IS 7100 A IS7100 A IS 7100A
Authority
IS
Iceland
Prior art keywords
sup
hydrogen atom
alkyl
independently represent
drugs
Prior art date
Application number
IS7100A
Other languages
English (en)
Other versions
IS2366B (is
Inventor
Auguet Michel
Chabrier De Lassauniere Pierre-Etienne
Harnett Jeremiah
Original Assignee
Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S), Société par Actions simplifiée
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S), Société par Actions simplifiée filed Critical Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S), Société par Actions simplifiée
Publication of IS7100A publication Critical patent/IS7100A/is
Publication of IS2366B publication Critical patent/IS2366B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Accessory Of Washing/Drying Machine, Commercial Washing/Drying Machine, Other Washing/Drying Machine (AREA)
  • Cleaning By Liquid Or Steam (AREA)
IS7100A 2001-07-26 2004-01-09 Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera IS2366B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109979A FR2827772B1 (fr) 2001-07-26 2001-07-26 Utilisation de derives de thiazoles pour preparer un medicament destine a proteger les mitochondries
PCT/FR2002/002660 WO2003009843A1 (fr) 2001-07-26 2002-07-25 Utilisation de derives de thiazoles pour preparer un medicament destine a proteger les mithochondries

Publications (2)

Publication Number Publication Date
IS7100A true IS7100A (is) 2004-01-09
IS2366B IS2366B (is) 2008-06-15

Family

ID=8865922

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7100A IS2366B (is) 2001-07-26 2004-01-09 Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera

Country Status (26)

Country Link
US (3) US7345066B2 (is)
EP (1) EP1414447B1 (is)
JP (1) JP4491229B2 (is)
KR (1) KR20040030843A (is)
CN (1) CN1533276B (is)
AT (1) ATE333876T1 (is)
AU (1) AU2002341008B8 (is)
BR (1) BR0211423A (is)
CA (1) CA2455635C (is)
CY (1) CY1106212T1 (is)
DE (1) DE60213424T2 (is)
DK (1) DK1414447T3 (is)
ES (1) ES2268099T3 (is)
FR (1) FR2827772B1 (is)
HK (1) HK1069326A1 (is)
HU (2) HU228783B1 (is)
IL (2) IL159548A0 (is)
IS (1) IS2366B (is)
MX (1) MXPA04000752A (is)
NO (1) NO334797B1 (is)
NZ (1) NZ530368A (is)
PL (1) PL206706B1 (is)
PT (1) PT1414447E (is)
RU (1) RU2297832C2 (is)
TW (1) TWI309568B (is)
WO (1) WO2003009843A1 (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291641B2 (en) * 1999-10-11 2007-11-06 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
US7101917B2 (en) 2003-04-14 2006-09-05 Hoffmann-La Roche Inc. Mitochrondrial permeability transition pore affinity labels and modulators
DE602007010821D1 (de) * 2006-10-24 2011-01-05 Congenia S R L Phenyl-substituierte maleimide als medikamente zur hemmung von degenerativen gewebeschäden durch hemmung von mpt
KR100970814B1 (ko) * 2009-06-01 2010-07-16 주식회사 동아지질 석션 드레인 공법에 사용되는 배수재 연결구
JP6958860B2 (ja) 2017-11-07 2021-11-02 学校法人自治医科大学 ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914207A (en) * 1989-05-09 1990-04-03 Pfizer Inc. Arylthiazolylimidazoles
ES2095960T3 (es) * 1990-09-25 1997-03-01 Rhone Poulenc Rorer Int Compuestos que tienen propiedades antihipertensivas y antiisquemicas.
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
FR2764889B1 (fr) * 1997-06-20 2000-09-01 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
DE69830410T2 (de) * 1997-08-29 2006-01-26 Tularik Ltd. Meta-benzamidinderivate als serinprotease-inhibitoren
US6518292B1 (en) * 1999-03-12 2003-02-11 Bristol-Myers Squibb Co. Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
JP2003502314A (ja) * 1999-06-14 2003-01-21 イーライ・リリー・アンド・カンパニー 化合物
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
FR2800615B1 (fr) * 1999-11-05 2002-05-03 Sod Conseils Rech Applic Produit comprenant au moins une substance inhibitrice des no synthases en association avec au moins une substance inhibitrice des phospholipases a2

Also Published As

Publication number Publication date
CA2455635C (fr) 2011-05-31
US20080039451A1 (en) 2008-02-14
EP1414447B1 (fr) 2006-07-26
KR20040030843A (ko) 2004-04-09
AU2002341008B2 (en) 2007-03-08
RU2297832C2 (ru) 2007-04-27
DE60213424D1 (de) 2006-09-07
RU2004105653A (ru) 2005-04-10
JP4491229B2 (ja) 2010-06-30
HUP0500557A2 (hu) 2005-09-28
US7345066B2 (en) 2008-03-18
CN1533276B (zh) 2010-06-30
IL159548A0 (en) 2004-06-01
DE60213424T2 (de) 2007-08-23
AU2002341008A1 (en) 2003-02-17
ATE333876T1 (de) 2006-08-15
HU229425B1 (en) 2013-12-30
HK1069326A1 (en) 2005-05-20
NO334797B1 (no) 2014-05-26
WO2003009843A1 (fr) 2003-02-06
EP1414447A1 (fr) 2004-05-06
AU2002341008B8 (en) 2007-08-09
JP2005500337A (ja) 2005-01-06
NO20040280L (no) 2004-01-21
HU0500484D0 (en) 2005-07-28
CA2455635A1 (fr) 2003-02-06
HUP0500557A3 (en) 2006-02-28
IS2366B (is) 2008-06-15
NZ530368A (en) 2005-04-29
IL159548A (en) 2009-11-18
HU228783B1 (en) 2013-05-28
TWI309568B (en) 2009-05-11
DK1414447T3 (da) 2006-11-27
US20040248885A1 (en) 2004-12-09
US20070185174A1 (en) 2007-08-09
ES2268099T3 (es) 2007-03-16
BR0211423A (pt) 2004-08-17
FR2827772A1 (fr) 2003-01-31
CN1533276A (zh) 2004-09-29
CY1106212T1 (el) 2011-06-08
PL206706B1 (pl) 2010-09-30
PL368315A1 (en) 2005-03-21
FR2827772B1 (fr) 2006-04-28
HUP0500484A3 (en) 2005-09-28
PT1414447E (pt) 2006-12-29
MXPA04000752A (es) 2004-04-20

Similar Documents

Publication Publication Date Title
HUP0303037A2 (hu) Alzheimer-kór kezelésére alkalmas vegyületek és ezeket tartalmazó gyógyszerkészítmények
DK1054874T3 (da) Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
DK1389617T3 (da) Heterocyclisk forbindelse og antitumormiddel indeholdende denne som den aktive bestanddel
DE602005027213D1 (de) Neue imidazolidinderivate
ATE158288T1 (de) Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate
NO20054787D0 (no) Indenderivater som farmasotiske midler
NO20014925D0 (no) Farmasöytiske forbindelser
CY1111909T1 (el) Παραγωγα [[2-(αμινο-3,4-διοξο-1-κυκλοβουτεν-1-υλ)amino] αλκυλ]-οξεος για τη θεραπεια του πονου
HK1069326A1 (en) Use of thiazole derivatives for preparing a medicine for protecting mitochondria
DE60116589D1 (de) Fungizide Phenylamidinderivative
EA200600607A1 (ru) Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы
AR010098A1 (es) COMPOSICION Y PROCEDIMIENTO PARA LA DEFORMACION PERMANENTE DEL CABELLO, Y PROCEDIMIENTO DE PREPARACIoN DE DICHA COMPOSICION
WO2005011697A3 (en) Sulfonamide derivatives with activity on protein kinase a and b
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
ATE243213T1 (de) Silizium-enthaltende ascorbinsäurederivate
ATE407923T1 (de) Tyrosinderivate als phosphatase inhibitoren
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
BG106156A (en) Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
DK0485219T3 (da) Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser
DE60108209D1 (de) Fungizide Phenylimidate-Derivate
CO5210951A1 (es) Mezclas fungicidas sinergicas de una azolopirimidina y una fenoxiamida inhibidora de la biosisntesis de melanina
DE60239491D1 (de) Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung
HUP0202340A2 (hu) Hatóanyagként kondenzált heterociklusos vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
TW200626007A (en) Material for electroluminescent element and electroluminescent element